Germline mutations of the RET proto-oncogene are responsible for the familial tumor syndrome called multiple endocrine neoplasia type 2 (MEN 2) that includes medullary thyroid carcinoma (MTC). Although inherited mutations of RET lead to tumor formation in patients with MEN 2, it is not understood why only selected cells develop into tumors. We have recently shown that duplication of the mutated RET allele or loss of the wild-type allele might represent mechanisms of tumorigenesis in patients with MEN 2A-related pheochromocytoma. We now analysed 19 DNA samples of MTC (15 of which were non-microdissected, four of which were microdissected) from patients with MEN 2A. Using polymorphic marker and phosphorimage densitometry analyses, we found allelic imbalance of the mutated and wild-type RET allele in six of 19 DNA MTC samples. Of note, two of the four microdissected tumor DNA samples showed allelic imbalance of RET, whereas only four of the 15 non-microdissected MTC samples did. These results underscore the signi®cance of microdissection in the analysis of tumor DNA. In our study, some of the non-microdissected tumor DNA samples may have failed to display allelic imbalance of RET, because of contamination of tumor DNA with nonneoplastic DNA or noninformative microsatellite marker analysis. Taken together, our results suggest allelic imbalance between mutated and wild-type RET as a possible mechanism for tumor formation in some patients with MEN 2A-related MTC. Oncogene (2001) 20, 7809 ± 7811
Germline mutations of the RET proto-oncogene are responsible for the familial tumor syndrome called multiple endocrine neoplasia type 2 (MEN 2) that includes medullary thyroid carcinoma (MTC). Although inherited mutations of RET lead to tumor formation in patients with MEN 2, it is not understood why only selected cells develop into tumors. We have recently shown that duplication of the mutated RET allele or loss of the wild-type allele might represent mechanisms of tumorigenesis in patients with MEN 2A-related pheochromocytoma. We now analysed 19 DNA samples of MTC (15 of which were non-microdissected, four of which were microdissected) from patients with MEN 2A. Using polymorphic marker and phosphorimage densitometry analyses, we found allelic imbalance of the mutated and wild-type RET allele in six of 19 DNA MTC samples. Of note, two of the four microdissected tumor DNA samples showed allelic imbalance of RET, whereas only four of the 15 non-microdissected MTC samples did. These results underscore the signi®cance of microdissection in the analysis of tumor DNA. In our study, some of the non-microdissected tumor DNA samples may have failed to display allelic imbalance of RET, because of contamination of tumor DNA with nonneoplastic DNA or noninformative microsatellite marker analysis. Taken together, our results suggest allelic imbalance between mutated and wild-type RET as a possible mechanism for tumor formation in some patients with MEN 2A-related MTC. Oncogene (2001) 20, 7809 ± 7811 Keywords: RET; MEN 2; medullary thyroid carcinoma; allelic imbalance Germline mutations of the RET proto-oncogene are associated with multiple endocrine neoplasia type 2 (MEN 2), an autosomal dominant inherited cancer syndrome. This syndrome is characterized by the development of medullary thyroid carcinoma (MTC), pheochromocytoma, and parathyroid hyperplasia adenoma (Mulligan et al., 1994) . In patients with MEN 2A-associated pheochromocytoma, we have recently found two possible mechanisms for tumorigenesis: duplication of the mutant RET allele or loss of the wild-type RET allele (Huang et al., 2000) . To investigate whether such a dominant eect of mutant RET might also be involved in tumor formation of MEN 2A-associated medullary thyroid carcinoma, we studied 19 tumor DNA samples from patients with MEN 2A-associated MTC and known RET germline mutations.
To analyse the allelic intensity of the mutant and the wild-type RET allele, we performed quantitative PCR on tumor DNA, using chromosome 10 microsatellite markers D10S1239, D10S677, D10S141, and RET. Upon direct visualization, six of the 19 dierent MTC DNA samples showed allelic imbalance (Figure 1 ). Quantitative analysis using phosphorimage densitometry revealed an intensity ratio of 2 : 1 between the mutant and the wild-type RET alleles in four of these six MTC DNA samples ( Figure 2 , Table 1 ). Blood DNA from the same patients revealed equal allelic intensities for informative chromosome 10 markers. The remaining 13 MTC DNA samples failed to display any imbalance between the two heterozygous alleles by microsatellite analysis with the aforementioned markers. In contrast to our former study with exclusively microdissected frozen tumor DNA from patients with MEN 2A-related pheochromocytoma, microdissected tumor DNA from patients with MEN 2A-related MTC was this time only available in four cases, whereas in 15 cases MTC tumor DNA was retrieved without histopathological control. Of the four microdissected MTC samples, two (50%) showed allelic imbalance of RET, whereas only four (25%) of the 15 nonmicrodissected MTC DNA samples also revealed allelic imbalance. All six cases of allelic RET imbalance had a ratio 41.8 (mutant : wild-type), whereas all`balanced' cases showed a ratio between 1.0 and 1.2 (mutant : wild-type, Figure 2 ). These results underscore the importance of microdissection for further tumor DNA analysis (Zhuang et al., 1995; . Non-microdissected MTC samples may have been heavily contaminated by nonneoplastic cells such as ®brous, vascular, and in¯ammatory cells, possibly obscuring allelic RET imbalance. However, two of our microdissected tissue samples also did not reveal either allelic imbalance or deletion of the wildtype RET allele. A possible explanation for the lack of demonstrating allelic imbalance in these samples may be focal RET duplication or ampli®cation that could not be detected with the polymorphic¯anking markers used. In addition, it is possible that these tumors developed by mechanisms other than allelic RET imbalance on chromosome 10 such as RET rearrangement through translocation or inversion (Cinti et al., 2000) or gross genomic changes (Lengauer et al., 1998) .
Inherited mutations of the RET proto-oncogene are responsible for the development of MEN 2-associated tumors such as medullary thyroid carcinoma. Although mutations of RET in the germline lead to tumor formation of the parafollicular C-cells in the thyroid gland and of the chroman cells in the adrenal medulla, it remains unclear why only selected cells (even though all cells in the target organs have the RET germline mutation) undergo tumorigenesis (Ponder, 1999 ). In addition, the time period of tumor formation is widely variable among patients with MEN 2, with some individuals who develop medullary thyroid carcinoma as late as in the 8th decade (Mulligan et al., 1994; Eng, 1996) . In patients with MEN 2A-associated pheochromocytoma, we recently provided evidence that tumor formation may occur by a`second hit' that causes a dominant eect of the mutant RET allele, either through duplication of the Figure 1 Allelic imbalance of mutant and wild-type RET in six representative cases of MEN 2A-associated medullary thyroid carcinoma. Each of the six samples shows decreased intensity of the wild-type allele in the tumor, as indicated by the arrow. T, tumor; N, normal tissue/blood; D10S677, D10S1239, polymorphic markers. Tumors were frozen at 7808C. DNA was extracted from lymphoblasts and tumor tissue by standard methods. In 15 cases, DNA was extracted from frozen tumor tissue without histomorphological control. DNA was stored frozen and received by us. In four of the 19 cases, frozen MTC tissue has been sent to us and tumor DNA been extracted by microdissection Figure 2 Representative results of microsatellite and phosphorimage analyses of ®ve dierent cases of MEN 2A-associated medullary thyroid carcinoma. After PCR ampli®cation of nonmicrodissected medullary thyroid tumor (T) and blood DNA (N) using polymorphic marker D10S677, quantitative measurement of allelic intensity was performed using phosphorimage analysis (Molecular Dynamics). A ratio of 1.5 : 1 or greater of the tumor DNA peak : germline DNA peak was operationally de®ned as allelic imbalance in heterozygous samples. All PCR reactions were performed in triplicate and were repeated twice. Each densitometry measurement was performed three times. Sample 2 is homozygous/noninformative. The tumor sample with the star (case 5 in the Table) demonstrates allelic imbalance with an allelic ratio of 2 : 1 by phosphorimage densitometry Codon 634 D10S677 1.9 Yes TGC/GGC * Representative markers that were informative mutant allele in trisomy 10 or loss of the normal wildtype RET (Huang et al., 2000) .
In the present study, we attempted to extend this concept to MEN 2A-associated MTCs. The mechanistic signi®cance of imbalance between the wild-type and the mutant oncogene has initially been shown in experimental mouse tumors and then in the human hereditary papillary renal cell carcinoma syndrome (Bianchi et al., 1990 . Inherited mutations of MET and/or RET may render the cells more susceptible to errors in chromosomal replication during cell division, resulting in non-random chromosomal duplication of the mutant allele or loss of the wild-type allele in those cells (Huang et al., 2000 . Such cells that contain two mutant RET alleles or exclusively the mutant RET allele may gain growth advantage and eventually develop into tumors. In our concept of dominant dosage of RET as a mechanism of tumorigenesis in MEN 2A-related MTC, the wild-type RET gene product initially might dimerize with the mutant counterpart, exerting a neutralizing eect and thereby partially compensating for the activating eects of the mutant RET allele. This protective eect of wild-type RET protein may disappear, once allelic imbalance of mutant and wild-type RET occurs, leading to an increased chance of dimerization between the mutant monomers. By such allelic imbalance of RET, susceptible cells within the thyroid in patients with MEN 2A might then develop into MTC. Thus, tumorigenesis in these patients may have been initiated by a RET germline mutation leading to hyperplasia of C-cells, followed by allelic imbalance of RET as à second activating hit' a mechanism similar to the`two hit' hypothesis of tumor-suppressor inactivation (Knudson, 1986) .
Materials and methods

Patients and tumors
All 19 patients were evaluated and treated at the Washington University, St. Louis, Georgetown University, Washington DC, or MD Anderson Cancer Center, Houston, TX. All patients had RET germline mutations and underwent at least total thyroidectomy for MTC. Tumors were frozen at 7808C. DNA was extracted from lymphoblasts and tumor tissue by standard methods. In 15 cases, DNA was extracted from frozen tumor tissue without histomorphological control. DNA was stored frozen and received by us. In four of the 19 cases, frozen MTC tissue has been sent to us and tumor DNA been extracted by microdissection (Zhuang et al., 1995 Quantitative PCR amplification of microsatellites on chromosome 10
We used four polymorphic markers, D10S1239, D10S677, RET and D10S141 (Research Genetics), in quantitative PCR analysis with genomic DNA extracted from peripheral blood and tumor and normal tissue. We performed PCR ampli®ca-tions in the presence of [a- 32 P] dCTP (0.1 mCi/ml) (Dupont) in a Hybaid Omnigene thermal cycler using Ampli-Taq Gold DNA polymerase (Perkin Elmer Roche). PCR conditions were as follows: initial denaturation at 958C for 10 min, then 30 cycles, each with 1 min of denaturation at 958C, 1 min of annealing at 558C, and 1 min of extension at 728C; PCR was completed with a ®nal extension at 728C for 10 min. The amplicons were resolved on a 6% polyacrylamide gel. Gels were dried and exposed to Kodak XAR ®lm. Quantitative analysis of allelic intensities/imbalance was performed using phosphorimage analysis (Molecular Dynamics). A ratio of 1.5 : 1 or greater of the tumor DNA peak : germline DNA peak was operationally de®ned as allelic imbalance in heterozygous samples. All PCR reactions were performed in triplicate and were repeated twice. Each densitometry measurement was performed three times.
